<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for RiboTargets - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/rib/rib000.html</link>
    <description>RiboTargets news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Fri, 25 Apr 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Fri, 25 Apr 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>License with Asinex extended</title>
      <description>"The ability to access such a wide range of chemical structures in our virtual screening programmes has been an important aspect of this collaboration"</description>
      <pubDate>Tue, 04 Feb 2003 08:00:00 UT</pubDate>
      <category>RiboTargets</category>
      <link>http://www.laboratorytalk.com/news/rib/rib107.html</link>
    </item>
    <item>
      <title>Beamlines for X-ray crystallography</title>
      <description>Structure-based drug discovery company RiboTargets joins the Partnership for Structural Biology at the European Synchrotron Radiation Facility</description>
      <pubDate>Wed, 29 Jan 2003 08:00:00 UT</pubDate>
      <category>RiboTargets</category>
      <link>http://www.laboratorytalk.com/news/rib/rib106.html</link>
    </item>
    <item>
      <title>EU puts bacteria in the frame</title>
      <description>European Union Fifth Framework project to discover new anti-microbials that target translation in bacteria and fungi</description>
      <pubDate>Thu, 12 Sep 2002 08:00:00 UT</pubDate>
      <category>RiboTargets</category>
      <link>http://www.laboratorytalk.com/news/rib/rib105.html</link>
    </item>
    <item>
      <title>Top safety award for drug discovery firm</title>
      <description>RiboTargets wins one of only 1000 National Safety Awards from the British Safety Council</description>
      <pubDate>Tue, 28 May 2002 08:00:00 UT</pubDate>
      <category>RiboTargets</category>
      <link>http://www.laboratorytalk.com/news/rib/rib104.html</link>
    </item>
    <item>
      <title>Appointment of new non-executive director</title>
      <description>Pharmaceutical research company RiboTargets announces the appointment of Christopher Samler, currently chief executive of Weston Medical, as a non-executive director</description>
      <pubDate>Wed, 15 May 2002 08:00:00 UT</pubDate>
      <category>RiboTargets</category>
      <link>http://www.laboratorytalk.com/news/rib/rib103.html</link>
    </item>
    <item>
      <title>License to 30S ribosome patents</title>
      <description>Bacterial ribosome research which highlighted several protein and nucleic acid ribosomal components now being taken forward in search for new antibacterial drugs</description>
      <pubDate>Tue, 09 Apr 2002 08:00:00 UT</pubDate>
      <category>RiboTargets</category>
      <link>http://www.laboratorytalk.com/news/rib/rib102.html</link>
    </item>
    <item>
      <title>Identifying protein inhibitors against cancer</title>
      <description>Three-way collaboration to identify and develop inhibitors of the HSP90 chaperone proteins as potential anti-cancer drugs</description>
      <pubDate>Fri, 05 Apr 2002 08:00:00 UT</pubDate>
      <category>RiboTargets</category>
      <link>http://www.laboratorytalk.com/news/rib/rib100.html</link>
    </item>
  </channel>
</rss>
